Patents by Inventor Anthony Clyde Blackburn

Anthony Clyde Blackburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isethionate salt of a selective CDK4 inhibitor
    Patent number: 7863278
    Abstract: Disclosed are polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.
    Type: Grant
    Filed: September 26, 2007
    Date of Patent: January 4, 2011
    Assignee: Warner-Lambert CompanyLLC
    Inventors: Vladimir Genukh Beylin, Anthony Clyde Blackburn, David Thomas Erdman, Peter Laurence Toogood
  • Isethionate salt of a selective CKD4 inhibitor
    Patent number: 7345171
    Abstract: Disclosed are polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.
    Type: Grant
    Filed: July 6, 2004
    Date of Patent: March 18, 2008
    Assignee: Warner-Lambert Company LLC
    Inventors: Vladimar G. Beylin, Anthony Clyde Blackburn, David Thomas Erdman, Peter Laurence Toogood